An open-label trial of citalopram for major depression in patients with hepatitis C

Journal of Clinical Psychiatry

Volumn 63, Issue 3, 2002, Pages 194-198

  Gleason, Ondria C ^a   Yates, William R ^a   Isbell, M Daniel ^a   Philipsen, Michelle A ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CITALOPRAM; GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS C; HUMAN; LIVER FUNCTION; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0036103097     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0304     Document Type: Article

References (25)

1. Epidemiology of hepatitis C
2. Recurrent and new hepatitis C virus infection after liver transplantation
3. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
4. Randomized trial of interferon alpha 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
5. Safety profile of interferon-α therapy
6. Randomized trial of α2b-interferon with or without indomethacin in patients with metastatic malignant melanoma
7. Interferons as mediators of psychiatric morbidity
8. Neurotoxicity of interferon-α
9. The alpha interferons: Clinical overview
10. Treatment of neurotoxic side effects of interferon-α with naltrexone
11. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
12. Depression, fatigue, and functional disability in patients with chronic hepatitis C
13. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
14. Limitations of diagnostic criteria and assessment instruments for mental disorders: Implications for research and policy
15. Hepatitis C and depression
16. Sertraline treatment of interferon-alfa-induced depressive disorder
17. Fluoxetine treatment of depression caused by interferon-alpha
18. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
19. Hamilton Depression Scale
20. Symptom Checklist-90-Revised (SCL-90-R)
21. The MOS 36-item short-form health survey (SF-36), 1: Conceptual framework and item selection
22. CGI: Clinical Global Impressions